175 related articles for article (PubMed ID: 32188406)
1. Cathepsin K regulates localization and secretion of Tartrate-Resistant Acid Phosphatase (TRAP) in TRAP-overexpressing MDA-MB-231 breast cancer cells.
Reithmeier A; Norgård M; Ek-Rylander B; Näreoja T; Andersson G
BMC Mol Cell Biol; 2020 Mar; 21(1):15. PubMed ID: 32188406
[TBL] [Abstract][Full Text] [Related]
2. Biogenesis of tartrate-resistant acid phosphatase isoforms 5a and 5b in stably transfected MDA-MB-231 breast cancer epithelial cells.
Zenger S; Ek-Rylander B; Andersson G
Biochim Biophys Acta; 2010 May; 1803(5):598-607. PubMed ID: 20149826
[TBL] [Abstract][Full Text] [Related]
3. The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells.
Krumpel M; Reithmeier A; Senge T; Baeumler TA; Frank M; Nyholm PG; Ek-Rylander B; Andersson G
Exp Cell Res; 2015 Nov; 339(1):154-62. PubMed ID: 26428664
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Zenger S; He W; Ek-Rylander B; Vassiliou D; Wedin R; Bauer H; Andersson G
Clin Exp Metastasis; 2011 Jan; 28(1):65-73. PubMed ID: 20967488
[TBL] [Abstract][Full Text] [Related]
6. Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells.
Reithmeier A; Panizza E; Krumpel M; Orre LM; Branca RMM; Lehtiö J; Ek-Rylander B; Andersson G
BMC Cancer; 2017 Sep; 17(1):650. PubMed ID: 28915803
[TBL] [Abstract][Full Text] [Related]
7. A Novel Sandwich ELISA for Tartrate-Resistant Acid Phosphatase 5a and 5b Protein Reveals that Both Isoforms are Secreted by Differentiating Osteoclasts and Correlate to the Type I Collagen Degradation Marker CTX-I In Vivo and In Vitro.
Mira-Pascual L; Patlaka C; Desai S; Paulie S; Näreoja T; Lång P; Andersson G
Calcif Tissue Int; 2020 Feb; 106(2):194-207. PubMed ID: 31654098
[TBL] [Abstract][Full Text] [Related]
8. Intensive weight gain therapy in patients with anorexia nervosa results in improved serum tartrate-resistant acid phosphatase (TRAP) 5a and 5b isoform protein levels.
Patlaka C; Tubic B; Lång P; Paulie S; Swolin-Eide D; Magnusson P; Andersson G
Eat Weight Disord; 2020 Oct; 25(5):1387-1397. PubMed ID: 31531762
[TBL] [Abstract][Full Text] [Related]
9. Naphthol-ASBI phosphate as a preferred substrate for tartrate-resistant acid phosphatase isoform 5b.
Janckila AJ; Takahashi K; Sun SZ; Yam LT
J Bone Miner Res; 2001 Apr; 16(4):788-93. PubMed ID: 11316008
[TBL] [Abstract][Full Text] [Related]
10. Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis.
Takahashi K; Janckila AJ; Sun SZ; Lederer ED; Ray PC; Yam LT
Clin Chim Acta; 2000 Nov; 301(1-2):147-58. PubMed ID: 11020469
[TBL] [Abstract][Full Text] [Related]
11. Tartrate-resistant acid phosphatase 5a and 5b contain distinct sugar moieties.
Kawaguchi T; Nakano T; Sasagawa K; Ohashi T; Miura T; Komoda T
Clin Biochem; 2008 Oct; 41(14-15):1245-9. PubMed ID: 18703035
[TBL] [Abstract][Full Text] [Related]
12. Identification of inhibitors of Tartrate-resistant acid phosphatase (TRAP/ACP5) activity by small-molecule screening.
Reithmeier A; Lundbäck T; Haraldsson M; Frank M; Ek-Rylander B; Nyholm PG; Gustavsson AL; Andersson G
Chem Biol Drug Des; 2018 Jul; 92(1):1255-1271. PubMed ID: 29500863
[TBL] [Abstract][Full Text] [Related]
13. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK
J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682
[TBL] [Abstract][Full Text] [Related]
14. The adipokine tartrate-resistant acid phosphatase 5a in serum correlates to adipose tissue expansion in obesity.
Patlaka C; Mira Pascual L; Paulie S; Henriksson AF; Arner P; Lång P; Andersson G
Biomarkers; 2017 Dec; 22(8):764-774. PubMed ID: 28532220
[TBL] [Abstract][Full Text] [Related]
15. Disease-specific expression of tartrate-resistant acid phosphatase isoforms.
Janckila AJ; Nakasato YR; Neustadt DH; Yam LT
J Bone Miner Res; 2003 Oct; 18(10):1916-9. PubMed ID: 14584907
[TBL] [Abstract][Full Text] [Related]
16. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity.
Perez-Amodio S; Jansen DC; Schoenmaker T; Vogels IM; Reinheckel T; Hayman AR; Cox TM; Saftig P; Beertsen W; Everts V
Calcif Tissue Int; 2006 Oct; 79(4):245-54. PubMed ID: 17033726
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia.
Ramesh J; Parthasarathy LK; Janckila AJ; Begum F; Murugan R; Murthy BPSS; El-Mallakh RS; Parthasarathy RN; Venugopal B
PLoS One; 2020; 15(3):e0230052. PubMed ID: 32214327
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Capeller B; Caffier H; Sütterlin MW; Dietl J
Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340
[TBL] [Abstract][Full Text] [Related]
19. Tartrate-resistant acid phosphatase type 5/ACP5 promotes cell cycle entry of 3T3-L1 preadipocytes by increasing IGF-1/Akt signaling.
Lång P; Patlaka C; Andersson G
FEBS Lett; 2021 Oct; 595(20):2616-2627. PubMed ID: 34418080
[TBL] [Abstract][Full Text] [Related]
20. Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis.
Park JK; Rosen A; Saffitz JE; Asimaki A; Litovsky SH; Mackey-Bojack SM; Halushka MK
Rheumatology (Oxford); 2013 Aug; 52(8):1529-33. PubMed ID: 23674817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
